Article FDA Thank You FDA updates guidance on developing drugs for Covid-19, replacing pandemic-era version
Agency IQ
DECEMBER 1, 2023
Now, the FDA has issued its first post-PHE version of this guidance Although the previous version of the guidance was revised to remain in effect until March 7, 2024, it has now been replaced. In addition, the guidance suggested that sponsors conduct antibody testing throughout the study to identify asymptomatic cases.
Let's personalize your content